RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Mamdooh Ghoneum to Cost-Benefit Analysis

Back to Details
This is a "connection" page, showing publications Mamdooh Ghoneum has written about Cost-Benefit Analysis.
Mamdooh Ghoneum
Connection Strength
0.134
Cost-Benefit Analysis
  1. Salama H, Medhat E, Shaheen M, Zekri AN, Darwish T, Ghoneum M. Arabinoxylan rice bran (Biobran) suppresses the viremia level in patients with chronic HCV infection: A randomized trial. Int J Immunopathol Pharmacol. 2016 Dec; 29(4):647-653.
    View in: PubMed
    Score: 0.134
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support